Gilead Sciences to Present at Upcoming Investor Conferences
Gilead Sciences (GILD) has announced its executives' participation in three upcoming investor conferences in September:
- Wells Fargo Healthcare Conference on September 4
- Morgan Stanley Annual Global Healthcare Conference on September 5
- Baird Global Healthcare Conference on September 10
Live webcasts will be available on Gilead's investor page, with replays accessible for at least 30 days. Gilead, a biopharmaceutical company with over three decades of experience, focuses on developing innovative medicines for life-threatening diseases like HIV, viral hepatitis, COVID-19, and cancer. Operating in more than 35 countries, Gilead is headquartered in Foster City, California.
Gilead Sciences (GILD) ha annunciato la partecipazione dei suoi dirigenti a tre prossime conferenze per investitori a settembre:
- Wells Fargo Healthcare Conference il 4 settembre
- Morgan Stanley Annual Global Healthcare Conference il 5 settembre
- Baird Global Healthcare Conference il 10 settembre
Saranno disponibili webcast dal vivo sulla pagina per investitori di Gilead, con repliche accessibili per almeno 30 giorni. Gilead, un'azienda biofarmaceutica con oltre tre decenni di esperienza, si concentra sullo sviluppo di farmaci innovativi per malattie potenzialmente letali come l'HIV, l'epatite virale, il COVID-19 e il cancro. Operando in oltre 35 paesi, Gilead ha sede a Foster City, California.
Gilead Sciences (GILD) ha anunciado la participación de sus ejecutivos en tres próximas conferencias para inversores en septiembre:
- Wells Fargo Healthcare Conference el 4 de septiembre
- Morgan Stanley Annual Global Healthcare Conference el 5 de septiembre
- Baird Global Healthcare Conference el 10 de septiembre
Estarán disponibles transmisiones en vivo en la página de inversores de Gilead, con repeticiones accesibles durante al menos 30 días. Gilead, una empresa biofarmacéutica con más de tres décadas de experiencia, se centra en desarrollar medicamentos innovadores para enfermedades potencialmente mortales como el VIH, la hepatitis viral, el COVID-19 y el cáncer. Con operaciones en más de 35 países, Gilead tiene su sede en Foster City, California.
길리어드 사이언스(GILD)가 9월에 있을 세 차례의 투자자 회의에 경영진이 참여한다고 발표했습니다:
- 웰스 파고 헬스케어 컨퍼런스: 9월 4일
- 모건 스탠리 연례 글로벌 헬스케어 컨퍼런스: 9월 5일
- 베어드 글로벌 헬스케어 컨퍼런스: 9월 10일
길리어드의 투자자 페이지에서 라이브 웹캐스트가 제공되며, 다시보기는 최소 30일간 이용할 수 있습니다. 길리어드는 30년 이상의 경험을 가진 생명공학 제약회사로, HIV, 바이러스성 간염, COVID-19 및 암과 같은 생명을 위협하는 질병에 대한 혁신적인 약물 개발에 집중하고 있습니다. 35개 이상의 나라에서 운영되고 있으며, 본사는 캘리포니아주 포스터 시티에 있습니다.
Gilead Sciences (GILD) a annoncé la participation de ses dirigeants à trois prochaines conférences pour investisseurs en septembre :
- Wells Fargo Healthcare Conference le 4 septembre
- Morgan Stanley Annual Global Healthcare Conference le 5 septembre
- Baird Global Healthcare Conference le 10 septembre
Des webdiffusions en direct seront disponibles sur la page des investisseurs de Gilead, avec des rediffusions accessibles pendant au moins 30 jours. Gilead, une entreprise biopharmaceutique ayant plus de trois décennies d'expérience, se concentre sur le développement de médicaments innovants pour des maladies menaces vitales comme le VIH, l'hépatite virale, le COVID-19 et le cancer. Opérant dans plus de 35 pays, Gilead a son siège à Foster City, Californie.
Gilead Sciences (GILD) hat die Teilnahme seiner Führungskräfte an drei bevorstehenden Investorenkonferenzen im September angekündigt:
- Wells Fargo Healthcare Conference am 4. September
- Morgan Stanley Annual Global Healthcare Conference am 5. September
- Baird Global Healthcare Conference am 10. September
Live-Webcasts werden auf der Investorenseite von Gilead verfügbar sein, mit Wiederholungen, die mindestens 30 Tage lang zugänglich sind. Gilead, ein biopharmazeutisches Unternehmen mit über drei Jahrzehnten Erfahrung, konzentriert sich auf die Entwicklung innovativer Medikamente für lebensbedrohliche Krankheiten wie HIV, Virushepatitis, COVID-19 und Krebs. Gilead ist in mehr als 35 Ländern tätig und hat seinen Hauptsitz in Foster City, Kalifornien.
- None.
- None.
- Wells Fargo Healthcare Conference on Wednesday, September 4 at 11:00 AM Eastern Time
- Morgan Stanley Annual Global Healthcare Conference on Thursday, September 5 at 12:20 PM Eastern Time
- Baird Global Healthcare Conference on Tuesday, September 10 at 10:50 AM Eastern Time
The live webcasts can be accessed at the company’s investors page at investors.gilead.com. The replays will be available for at least 30 days following the presentation.
About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in
For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240821963609/en/
Jacquie Ross, CFA – Investors
investor_relations@gilead.com
Source: Gilead Sciences, Inc.
FAQ
When is Gilead Sciences (GILD) presenting at the Wells Fargo Healthcare Conference?
What investor conferences is Gilead Sciences (GILD) attending in September 2024?
How can investors access Gilead Sciences' (GILD) conference presentations?
What are the main areas of focus for Gilead Sciences (GILD)?
